Why the study?
EuroSCORE II incorporates insulin-controlled diabetes but omits tablet-controlled diabetes, and differences in adverse clinical outcomes after CABG between these groups are poorly established.
Does the type of diabetes treatment (insulin vs. tablet) affect short and longer term mortality and morbidity in patients undergoing isolated first-time CABG compared to non-diabetics?
Population
8241 patients undergoing isolated first-time coronary artery bypass graft surgery
Comparison
Insulin-controlled diabetes vs tablet-controlled diabetes vs non-diabetic patients
Design
Propensity-matched study
Authors
Loading...
May support refining EuroSCORE II to include tablet-controlled diabetes in CABG; leaves open prospective validation.
Does the type of diabetes treatment (insulin vs. tablet) affect short and longer term mortality and morbidity in patients undergoing isolated first-time CABG compared to non-diabetics?
Both insulin- and tablet-controlled diabetes are independent risk factors for distinct adverse outcomes after CABG, highlighting the need for improved risk stratification and post-operative cardiovascular risk management.
Haqzad et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: